Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > News without news😃
View:
Post by SleepyHoward on Apr 25, 2023 6:45am

News without news😃

The following results were recently obtained:
Clinical Trial Results TFC-1326
• Increased Skin Density (Collagen and Elastin) by 37% 
• Decreased inflammation by 54%
• Decreased oxidation by 54%
• Increased skin radiance by 25%
• Decreased skin laxity
• Remodeled the oval of the face
• Visibly reduced fine wrinkles
• Tolerated by 100% of participants, even on sensitive skin
*Additional results are provided in our trial results news release and on our website
 
https://www.sironabiochem.com/wp-content/uploads/2023/04/Sirona-TFC-1326-vertical-April-25-1.pdf
Comment by SleepyHoward on Apr 25, 2023 6:48am
Was it a mistake to put the homepage online?  You never know with this unprofessionell management. Waiting for the news.  Bought more shares
Comment by Pareto8020 on Apr 25, 2023 7:06am
OMG - they can't even get a news release done properly!   At what point is someone at SBM going to be shown the door for incompetence!!?? So they have major material news and they slide it out in a presentation posted on their website without a NR -wtf!?
Comment by Pareto8020 on Apr 25, 2023 7:09am
On the plus side the results do seem visibly impressive! Too bad they don't know how to promote this company or results in general.  This could have been a real launch pad for them given the proper promotion and build up.  Instead complete silence followed by slippnig the results into a powerpoint presentation buried on their website. 
Comment by emerald03 on Apr 25, 2023 7:23am
Sleepy well done.We suspected results would be available.These seem breakthrough results to me  These results look outstanding  ,increased skin density by 37 percent in only 12 weeks ,OMG ,with decreased skin laxity and  visibly reduced fine wrinkles.So seems like it meets endpoints desired. We should finally be on our way ,with a strong confirmatory  news release for ...more  
Comment by biorun on Apr 25, 2023 7:30am
Seriously? This is very very bizarre especially when you actually look at the scientific results. Why is this not hitting the news wire for pests sake? Density, inflammation and oxidation 37 to 54%? Those look like statistically very massive numbers? I am not a skin clinician but this clearly looks on surface as impactful if not better than filling your face with needles?  So these results ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities